Zentalis Pharmaceuticals Awards Stock Options to New Hires Under Nasdaq Inducement Plan
Zentalis Pharmaceuticals granted 36,000 stock options at $2.57/share to two new hires under Nasdaq inducement rules, vesting over four years.
ZNTLstock optionsemployee compensation